10 NOV 2025 · CONFERENCE

Advancing circular mRNA therapeutics in Asia

At RNA Therapeutics & Manufacturing Asia, Byterna discussed circular mRNA innovation and in vivo CAR-T development.

RNA Asia 2025 event branding and conference audience — RNA Therapeutics & Manufacturing Asia 2025 conference cover from Byterna’s WeChat announcement.

Andy Xian Zeng moderated a C-suite discussion on advancing RNA medicines toward clinical reality and presented Byterna’s work in circular mRNA therapeutics and in vivo CAR-T.